Navigation Links
Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: BFNH, BKYI, RBCL
Date:4/1/2008

NEW YORK, April 1, 2008 /PRNewswire/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.

Shows air Monday through Friday on: http://www.wallst.net/wallst_tv/3_minute_press_show/index_wallst.php.

WallSt.net's 3-Minute Press Show features in-depth interviews with public company executives on their company and most recent press releases. The show is designed to provide viewers with insight into a company's most recent press release, and its impact on the company's growth.
The following executives were interviewed the show:

-- Greg Brown, Chief Financial Officer for BioForce Nanosciences Holdings,

Inc. (OTC Bulletin Board: BFNH) (http://www.bioforcenano.com)

-- Michael DePasquale, President and CEO of BIO-key International, Inc.

(OTC Bulletin Board: BKYI) (http://www.bio-key.com)

-- Paul Miller, President of MPM Medical, Inc., a wholly-owned subsidiary

of RBC Life Sciences, Inc.

(OTC Bulletin Board: RBCL) (http://www.rbclifesciences.com)

About WallStreet Direct, Inc.

WallStreet Direct, Inc. a wholly-owned subsidiary of Financial Media Group, Inc., owns and operates WallSt.net (http://www.wallst.net), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net) an online hub for business podcasts from well-known business news personalities and publishers. We have received
'/>"/>

SOURCE WallStreet Direct, Inc.; BioForce Nanosciences Holdings,Inc.;
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. lifesDHA(TM) Featured in New Ricos(R) Cheese Sauce
2. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
3. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
4. Synvista Therapeutics to be Featured on Wallst.net
5. Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
7. Marteks lifesDHA(TM) Now Featured in Two New Flavors of Rachels(R) Wickedly Delicious Yogurt from WhiteWave Foods
8. CardioDynamics BioZ(R) ICG Technology Featured in American College of Cardiology (ACC) Audio Series
9. CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference
10. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
11. CT Laser Mammography Technology to be Featured at European Congress of Radiology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NEW YORK, Dec. 2 /PRNewswire-USNewswire/ ...sts, policy makers, and funders today convened to ...e funding strategies at the inaugural Partnering ...ington-based center of the Milken Institute, conve...tor collaborations needed to turn a scientific dis...
(Date:12/2/2009)... , LIBREVILLE, Gabon, December 2 /PRNews...Africa: Everyone,s Problem and Heritage" , ...ersity, 2-3 June 2010 the,Gabonese Republic is hos...bon) on the issue of safeguarding biological resou... government and state leaders, ministers,scientif...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*...its novel oral JAK2 inhibitor, SB1518, at The Amer... Exposition in New Orleans. ,, Data will be pre...se-escalation trial of SB1518 detailing its safety... (PK/PD) profile in dose levels ranging from 100 t...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ ... markets are in turmoil and uncertainty is part of... the pharma industry has been,relatively immune to...ke a,vacation. , During the midst of the ...t Johnson & Johnson inaugurated an R&D cen...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...TI) (Nasdaq: CTIC ; MTAX) management will present...e on Tuesday, March 18 at 9:00 AM Pacific Time,(PT...nce Center., The presentation will also be webcas... the presentation. The webcast can be accessed at,... WBBA Invest Northwest Conference ...
...drian Seeman has received the American Chemical So...shing the field of structural DNA nanotechnology. ...izes outstanding contributions in the field of che...on. , Seeman, the Margaret and Herman Sokol Prof...he field of DNA nanotechnology--which is now pursu...
... March 19 at 10:00 AM EDT, CEDAR KNOLLS, N.J., Ma...S ) today announced its financial results for,the ... Emisphere will host a conference call to discuss ...March 19, 2008. A live webcast of the conference,c... at: http://www.emisphere.com .,The live conferen...
Other Biology Technology:Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 2Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 3Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 4Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 5Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 6Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 7Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results 8
(Date:12/3/2009)...er felt overly upset by a social snubbing? Your ge...entists have long known that opium-like painkiller... but also some forms of emotional stress. Now, a n...r Markus Heilig shows that small genetic differenc...ne the intensity of people,s responses to social r...
(Date:12/3/2009)...A team of scientists from the U.S. Department of E...ard University, and the Indian Institute of Scienc...ules locate the genetic information in DNA that is...sses. The research, published in the December 1, 2...ogy , confirms that many proteins responsible for ...
(Date:12/2/2009)...HIA New study results strengthen the evidence tha...f time have an increased risk for developing color...factors. , "This provides one more reason not t...ior author Michael J. Thun, M.D., M.S., vice presi...rch at the American Cancer Society. "Colorectal ca...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Cepheid Announces Accelerated Development of Flu A Panel Test 56528 1Cepheid Announces Accelerated Development of Flu A Panel Test 56528 2Cepheid Announces Accelerated Development of Flu A Panel Test 56528 3Cepheid Announces Accelerated Development of Flu A Panel Test 56528 4DNA Genotek 26apos 3Bs Oragene 26amp 3B 239679 3BANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in D 13925 1DNA Genotek 26apos 3Bs Oragene 26amp 3B 239679 3BANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in D 13925 2DNA Genotek 26apos 3Bs Oragene 26amp 3B 239679 3BANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in D 13925 3Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 1Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 2Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 3Prometheus Announces Co Pay Assistance Savings Program for LOTRONEX 28R 29 28alosteron HCl 29 Tablets 56526 4
...rauma patients, every second counts. Yet bruises, ... difficult to locate veins and administer lifesavi...orgia Institute of Technology researchers is devel...ppler ultrasound technology to find veins quickly....vessel detection," says project leader Michael Gra...
... and extreme athletes, lactic acid is poison, a wa...s to muscle fatigue, reduced performance and pain....California, Berkeley, however, tells a different s...nd athletes don,t realize it, says exercise physio...egrative biology, but endurance training teaches t...
...sweet lure of chocolate or the bitter taste of str...responses be so innate as to be hard-wired into th...lable fruit fly Drosophila, Kristin Scott and coll...Neuron experiments demonstrating just such a hard-...r a model for taste encoding in the brain that hol...
Other Biology News:Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 2Lactic acid not athlete's poison, but an energy source - if you know how to use it 3Lactic acid not athlete's poison, but an energy source - if you know how to use it 4How taste response is hard-wired into the brain 2
Rabbit Anti-SERHL Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-MDMA Monoclonal Antibody, Unconjugated, Clone 3G8 from ProSci, Inc
Mouse Anti-HDV Antibody, Unconjugated from Raybiotech, Inc.
Mouse Anti-zona radiata Monoclonal Antibody, Unconjugated, Clone MN-8C4 from Abcam
Biology Products: